CD276 and cancer: Conversely, markers linked to suppressive myeloid cell populations (VISTA, B7-H3, CD163) and T cells (Tim-3, LAG3, CD4) showed heightened expression levels within CD45+ segments of the surrounding stromal leukocytes compared to regions comprising immune-rich cancer cell islets [474].